Board welcomes Andrew Mills as CEO
The Board of Arthritis Australia is pleased to announce we have appointed Andrew Mills as our new CEO.
“Andrew brings a wealth of experience in the health sector, not-for-profit organisations and the corporate sector. His skills will be invaluable as we move into a new era of partnering with government to develop and implement a National Arthritis Action Plan.
Our former CEO left an impressive legacy through programs including National Research, ease of use testing, consumer education resources, and consumer advocacy. We are looking forward to working with Andrew to support and empower all Australians affected by arthritis,” said Kristine Riethmiller, Chair of Arthritis Australia.
“We have some exciting and challenging work ahead of us,” Andrew said. “The next 6–12 months will be critically important to the organisation, as we build upon our advocacy work to develop and implement the National Strategic Action Plan for Arthritis with the Australian Government.”
“With 4 million Australians living with arthritis, and a majority of them not coping with their pain and disability, our role is more clear than ever: to help all Australians living with arthritis to live their best quality life,’ said Andrew.
Andrew Mills, CEO
(02) 9518 4441
Lindsey Parks, Digital & Social
(04) 22 491 963
Australian Rheumatology Association and Arthritis Australia Statement regarding the use of glucosamine for the treatment of Osteoarthritis
Recent media reports have raised concern over the use of glucosamine in the treatment of osteoarthritis. These reports appear to be based on two unrelated...
UPDATED: Advice regarding Coronavirus (Covid-19) from the Australian Rheumatology Association
Due to the increasing number of infections in Australia from Coronavirus (Covid-19), we are aware of growing concerns raised by patients with chronic illnesses and...
New campaign reveals blind spot for older Australians
Arthritis Australia is urging older Australians to look out for symptoms of silent inflammation that could put their eyesight at risk, and to speak to...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: